{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16170989", "DateCompleted": {"Year": "2005", "Month": "11", "Day": "03"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0019-5499", "JournalIssue": {"Volume": "49", "Issue": "2", "PubDate": {"Year": "2005", "Month": "Apr"}}, "Title": "Indian journal of physiology and pharmacology", "ISOAbbreviation": "Indian J Physiol Pharmacol"}, "ArticleTitle": "An experimental evaluation of anticonvulsant activity of Vitex-negundo.", "Pagination": {"StartPage": "199", "EndPage": "205", "MedlinePgn": "199-205"}, "Abstract": {"AbstractText": ["Maximal electroshock seizures (MES) in albino rats and pentylenetetarazole (PTZ) induced seizures in albino mice were used to study anticonvulsant activity of Vitex-negundo leaf extract. The ethanolic leaf extract of Vitex-negundo was administered orally in graded doses (250, 500 and 1000 mg/kg p.o) in both the experimental models and the effects were compared with diphenylhydantoin in MES method and valporic acid in PTZ induced seizures method as standard control respectively. The Vitex-negundo in the doses (250, 500 and 1000 mg/kg, p.o) did not show protection against MES to any significant extent but significant post-ictal depression was observed in the dose of 1000 mg/kg body weight in comparison to control. However, sub-protective dose of test drug (100 mg/ kg, p.o) potentiated the anticonvulsant action of diphenylhydantoin. The test drug in the dose (1000 mg/kg, po) showed 50% protection in clonic seizures and 24-hour mortality against PTZ induced seizures. It also decreased number and duration of convulsions significantly. Vitex-negundo potentiated anticonvulsant activity of valporic acid. The anticonvulsant activity of Vitex-negundo has not been found equi-effective with standard drugs. These findings suggest that Vitex-negundo possesses anticonvulsant activity particularly against PTZ induced convulsions. Moreover, the potentiation of diphenylhydantoin and valporic acid by Vitex-negundo indicates that it may be useful as an adjuvant therapy along with standard anticonvulsants and can possibly lower the requirement of diphenylhydantoin and valporic acid."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Post Graduate Department of Pharmacology & Therapeutics, Govt. Medical College, Jammu 180 001. dr_vishaltandon@yahoo.com"}], "Identifier": [], "LastName": "Tandon", "ForeName": "V R", "Initials": "VR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gupta", "ForeName": "R K", "Initials": "RK"}], "PublicationTypeList": ["Comparative Study", "Evaluation Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "Indian J Physiol Pharmacol", "NlmUniqueID": "0374707", "ISSNLinking": "0019-5499"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "614OI1Z5WI", "NameOfSubstance": "Valproic Acid"}, {"RegistryNumber": "6158TKW0C5", "NameOfSubstance": "Phenytoin"}, {"RegistryNumber": "WM5Z385K7T", "NameOfSubstance": "Pentylenetetrazole"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Electroshock"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Pentylenetetrazole"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phenytoin"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plant Leaves"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Reference Standards"}, {"QualifierName": ["chemically induced", "etiology", "prevention & control"], "DescriptorName": "Seizures"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Valproic Acid"}, {"QualifierName": [], "DescriptorName": "Vitex"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "9", "Day": "21", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "11", "Day": "4", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "9", "Day": "21", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16170989"]}}], "PubmedBookArticle": []}